Contact
searchSearch
HMP Global
Login
Interview
Telegenetic Counseling Proves Beneficial for Patients With Cancer and Their Care Providers
04/06/2021
Rachel McConachie, RN, BSN, Dignity Health Cancer Institute of Greater Sacramento, discusses how her cancer center has adapted to providing patients with telemedicine-driven genetic counseling.
Rachel McConachie, RN, BSN, Dignity Health Cancer Institute of Greater Sacramento, discusses how her cancer center has adapted to providing patients with telemedicine-driven genetic counseling.
Rachel McConachie, RN, BSN,...
04/06/2021
Oncology
Conference Insider
Experts Discuss Cancer Care in the COVID Era at the ACCC Annual Meeting – Part II
03/03/2021
At the Virtual ACCC Annual Meeting & Cancer Center Business Summit, experts convened to discuss real-world experiences and challenges associated with the pandemic.
At the Virtual ACCC Annual Meeting & Cancer Center Business Summit, experts convened to discuss real-world experiences and challenges associated with the pandemic.
At the Virtual ACCC Annual...
03/03/2021
Oncology
Conference Insider
Experts Discuss Cancer Care in the COVID Era at the ACCC Annual Meeting – Part I
03/03/2021
At the Virtual ACCC Annual Meeting & Cancer Center Business Summit, a panel of healthcare professionals discussed real-world experiences on the challenges of COVID-19 and its effect on cancer care.
At the Virtual ACCC Annual Meeting & Cancer Center Business Summit, a panel of healthcare professionals discussed real-world experiences on the challenges of COVID-19 and its effect on cancer care.
At the Virtual ACCC Annual...
03/03/2021
Oncology
News
Overcoming Hurdles in the Delivery of Cancer Care
02/24/2021
From March 1-5, cancer care professionals from a variety of specialties and care delivery settings will convene virtually for the ACCC 47th Annual Meeting & Cancer Center Business Summit.
From March 1-5, cancer care professionals from a variety of specialties and care delivery settings will convene virtually for the ACCC 47th Annual Meeting & Cancer Center Business Summit.
From March 1-5, cancer care...
02/24/2021
Oncology
Interview
Improving the Cancer Patient Experience, Representation at the Policy Level
03/26/2020
Rebecca Kirch, JD, discusses the latest efforts of the National Patient Advocate Foundation and the ACCC tiered matrix of services that are specific to improving the patient experience.
Rebecca Kirch, JD, discusses the latest efforts of the National Patient Advocate Foundation and the ACCC tiered matrix of services that are specific to improving the patient experience.
Rebecca Kirch, JD, discusses the...
03/26/2020
Oncology
Interview
Urgent Symptom Support, Pathways to Reduce ED Use, Care Variation
03/20/2020
Mike Koroscik, MHA, MBA, discusses successful strategies to reduce ED visits and hospitalizations in the community setting.
Mike Koroscik, MHA, MBA, discusses successful strategies to reduce ED visits and hospitalizations in the community setting.
Mike Koroscik, MHA, MBA,...
03/20/2020
Oncology
Interview
Design Implications for Multidisciplinary Community Care: TriHealth Cancer Institute
03/20/2020
Mark G. Witte discusses multidisciplinary care at the largest cancer care provider in the greater Cincinnati region.
Mark G. Witte discusses multidisciplinary care at the largest cancer care provider in the greater Cincinnati region.
Mark G. Witte discusses...
03/20/2020
Oncology
Podcasts
ACCC President Talks Community Oncology and Bridging the Research Gap
03/18/2020
Randall A. Oyer, MD, ACCC President, discusses his presidency theme, entitled “Community Oncology Can Close the Gap in Cancer Research.”
Randall A. Oyer, MD, ACCC President, discusses his presidency theme, entitled “Community Oncology Can Close the Gap in Cancer Research.”
Randall A. Oyer, MD, ACCC...
03/18/2020
Oncology
Podcasts
Direct-to-Patient Strategies in Multiple Myeloma Care
03/13/2020
Anne Quinn Young, MPH, discusses direct-to-patient efforts in myeloma care that are poised to help improve data accumulation and ultimately provide precision therapies for patients.
Anne Quinn Young, MPH, discusses direct-to-patient efforts in myeloma care that are poised to help improve data accumulation and ultimately provide precision therapies for patients.
Anne Quinn Young, MPH, discusses...
03/13/2020
Oncology

At the Association of Community Cancer Centers (ACCC) Annual Meeting & Cancer Center Business Summit, experts in the oncology space convene to share and discuss the latest advancements in cancer care.

What Your Colleagues Are Reading

Jane Meisel, MD
Conference Coverage
Antibody Drug Conjugates for Patients With Metastatic Breast Cancer
06/02/2024
Jane Meisel, MD, discusses the impact novel antibody drug conjugates have had in the treatment of patients with metastatic breast cancer.
Jane Meisel, MD, discusses the impact novel antibody drug conjugates have had in the treatment of patients with metastatic breast cancer.
Jane Meisel, MD, discusses the...
06/02/2024
Oncology
FDA Approval
FDA Approves Selpercatinib for Adult and Pediatric Patients With RET Fusion-Positive Thyroid Cancer
06/13/2024

Stephanie Holland 

Stephanie Holland 
Based on results from the LIBRETTO-001 and the LIBRETTO–121 studies, the FDA has approved selpercatinib for adult and pediatric patients with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and are...
Based on results from the LIBRETTO-001 and the LIBRETTO–121 studies, the FDA has approved selpercatinib for adult and pediatric patients with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and are...
Based on results from the...
06/13/2024
Oncology
Aaron Gerds, MD
Videos
Novel Updates in Frontline Myelofibrosis Treatment Research
06/25/2024
Aaron Gerds, MD, discusses data from the MANIFEST-2 and TRANSFORM-1 trials exploring first-line treatment options for patients with myelofibrosis, as well as analyzes the establishment of optimal clinical trial end points.
Aaron Gerds, MD, discusses data from the MANIFEST-2 and TRANSFORM-1 trials exploring first-line treatment options for patients with myelofibrosis, as well as analyzes the establishment of optimal clinical trial end points.
Aaron Gerds, MD, discusses data...
06/25/2024
Oncology
News
Adjuvant Dabrafenib Plus Trametinib Improved Long-Term Survival Among Patients With Advanced-Stage Melanoma Harboring BRAF V600 Mutations
07/11/2024
Stephanie Holland
According to final analysis results from the phase 3 COMBI-AD trial, adjuvant dabrafenib plus trametinib improved long-term recurrence-free and distant metastasis-free survival compared to placebo among patients with stage 3 melanoma...
According to final analysis results from the phase 3 COMBI-AD trial, adjuvant dabrafenib plus trametinib improved long-term recurrence-free and distant metastasis-free survival compared to placebo among patients with stage 3 melanoma...
According to final analysis...
07/11/2024
Oncology
Paula Rodríguez-Otero, MD
Videos
Daratumumab Plus Bortezomib, Lenalidomide and Dexamethasone for Transplant-Eligible Patients With Newly Diagnosed MM
07/27/2024
Paula Rodríguez-Otero, MD, highlights results supporting the use of daratumumab plus bortezomib, lenalidomide and dexamethasone as a standard of care treatment for transplant-eligible patients with newly diagnosed multiple myeloma.
Paula Rodríguez-Otero, MD, highlights results supporting the use of daratumumab plus bortezomib, lenalidomide and dexamethasone as a standard of care treatment for transplant-eligible patients with newly diagnosed multiple myeloma.
Paula Rodríguez-Otero, MD,...
07/27/2024
Oncology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use